-
莫西菌素
- names:
Moxidectin
- CAS号:
113507-06-5
MDL Number: MFCD00866560 - MF(分子式): C37H53NO8 MW(分子量): 639.82
- EINECS: Reaxys Number:113507-06-5
- Pubchem ID:16760141 Brand:BIOFOUNT
货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
---|---|---|---|---|---|---|---|---|
YZM000785-50mg | 50mg | 96.42% | ¥ 1320.00 | ¥ 1320.00 | Instock1-2days | ¥ 0.00 | ||
YZM000785-10mg | 10mg | 96.42% | ¥ 420.00 | ¥ 420.00 | Instock1-2days | ¥ 0.00 |
中文别名 | 莫西菌素(Moxidectin,113507-06-5) |
英文别名 | Moxidectin(莫西菌素,113507-06-5) |
CAS号 | 113507-06-5 |
SMILES | C/C([C@H]([C@H](/C1=N/OC)C)O[C@]2(C1)C[C@](OC([C@@](C=C(C)[C@@H](O)[C@@]3([H])OC/C4=C\C=C\[C@H](C)C5)([H])[C@@]34O)=O)([H])C[C@](C/C=C5\C)([H])O2)=C\C(C)C |
Inchi | InChI=1S/C37H53NO8/c1-21(2)14-25(6)33-26(7)31(38-42-8)19-36(46-33)18-29-17-28(45-36)13-12-23(4)15-22(3)10-9-11-27-20-43-34-32(39)24(5)16-30(35(40)44-29)37(27,34)41/h9-12,14,16,21-22,26,28-30,32-34,39,41H,13,15,17-20H2,1-8H3/b10-9+,23-12+,25-14+,27-11+,38-31+/t22-,26-,28+,29-,30-,32+,33+,34+,36-,37+/m0/s1 |
InchiKey | YZBLFMPOMVTDJY-LSGXYNIPSA-N |
分子式 Formula | C37H53NO8 |
分子量 Molecular Weight | 639.82 |
闪点 FP | 431.6±35.7 °C |
熔点 Melting point | No data available |
沸点 Boiling point | 790.0±70.0 °C at 760 mmHg |
Polarizability极化度 | 68.4±0.5 10-24cm3 |
密度 Density | 1.2±0.1 g/cm3 |
蒸汽压 Vapor Pressure | 0.0±6.2 mmHg at 25°C |
溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 42 mg/mL(65.64 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
性状 | 固体粉末,Power |
储藏条件 Storage conditions | -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
Tag:莫西菌素MSDS,莫西菌素蒸汽压,莫西菌素合成,莫西菌素标准,莫西菌素应用,莫西菌素合成,莫西菌素沸点,莫西菌素闪点,莫西菌素用途,莫西菌素溶解度,莫西菌素价格,莫西菌素作用,莫西菌素结构式,莫西菌素用处,莫西菌素毒理性质,莫西菌素物理性质
产品说明 | 莫西菌素(Moxidectin,113507-06-5)是一种链霉菌发酵产生的半合成单一成分的大环内酯类抗生素,莫西菌素是尼莫克汀的衍生物。 |
Introduction | Moxidectin(莫西菌素,113507-06-5) is a semi-synthetic single-component macrolide antibiotic produced by the fermentation of Streptomyces. Moxicillin is a derivative of Nimectin. |
Application1 | Moxidectinis an anthelmintic drug which kills parasitic worms (helminths), and is used for the prevention and control of heartworm and intestinal worms.IC50 value: |
Application2 | |
Application3 |
警示图 | |
危险性 | warning |
危险性警示 | Not available |
安全声明 | H303吞入可能有害+H313皮肤接触可能有害+H2413吸入可能对身体有害 |
安全防护 | P264处理后彻底清洗+P280戴防护手套/穿防护服/戴防护眼罩/戴防护面具+P305如果进入眼睛+P351用水小心冲洗几分钟+P338取出隐形眼镜(如果有)并且易于操作,继续冲洗+P337如果眼睛刺激持续+P2393获得医疗建议/护理 |
备注 | 实验过程中防止吸入、食入,做好安全防护 |
A comparison of the efficacy of subcutaneously administered ivermectin, doramectin, and moxidectin against naturally infected Toxocara vitulorum in calves Tropical Animal Health and Prod/PMID:21350848 |
Effectiveness evaluation of several cattle anthelmintics via the fecal egg count reduction test Parasitology Research 2009/PMID: 19214571 |
Anthelminthic resistance of Haemonchus contortus in small ruminants in Switzerland and Southern Germany Wiener klinische Wochenschrift 2009/PMID: 19915817 |
Anthelmintic efficacy against gastrointestinal nematodes in goats raised under mountain farming conditions in northern Italy BMC Veterinary Research 2019/PMID: 31248417 |
A comparative kinetic study of doramectin and moxidectin in zebu Gobra cattle (Bos indicus) Parasitology Research 2008/PMID: 18679717 |
First report of multiple drug resistance in trichostrongyles affecting sheep under field conditions in Italy
Abstract
Drug resistance in sheep gastrointestinal trichostrongyles is a cosmopolitan major constraint to small ruminant production. Despite reports that anthelmintic drug resistance has become common, there are limited information on the presence of drug resistance in Italy. The purpose of this study was to determine the effect of four anthelmintics to control infection in sheep in central Italy. Fifty sheep with fecal egg counts (FEC) > or =150 eggs per gram were selected on each of three farms (n = 150 total sheep) which were randomly allocated to one of five groups. Groups were treated with febantel, levamisole, ivermectin, or moxidectin while the fifth group acted as the control group. A FEC reduction test (FECRT) was conducted on each animal and the mean FEC of each treatment group was compared to that of the control group within farm. Resistance was declared when percentage reduction (R) <95% and the lower 95% confidence interval was <90%. Levamisole (mean R = 89%) resistance was found on all farms and ivermectin (mean R = 93%) resistance was found on two of the three farms. Posttreatment larval cultures showed the presence of Teladorsagia (Ostertagia) circumcincta and Trichostrongylus spp. larvae. Febantel (mean R = 96%) and moxidectin (mean R = 100%) remained effective. This study suggests that drug resistance in sheep gastrointestinal trichostrongyles is present in central Italy and a potential problem which would justify a broader nationwide geographical investigation.
The effect of moxidectin 0,1% vs ivermectin 0,08% on milk production in sheep naturally infected by gastrointestinal nematodes
Abstract:
Background: Gastrointestinal nematode (GIN) infection is one of the main constraints to sheep production both in temperate and tropical countries. Economic losses caused by GIN are related to decreased production, treatment costs and even animal death. The present paper was aimed at assessing the anthelmintic efficacy (based on faecal egg count reduction) of moxidectin and ivermectin both administered per os at dose rate of 0.2 mg/Kg body weight and the benefit of anthelmintic treatments on milk production in a commercial dairy sheep farms in central Italy whose animals were naturally infected by GIN.
Results: The treatment with moxidectin was highly effective (> 98%) from day 7 until day 75, and effective (90-98%) until day 105. The treatment with ivermectin was highly effective (> 98%) from day 7 until day 14, effective (90-98%) at day 28 and moderately effective (80-89%) on day 45. The milk productions in the treated groups were significantly higher than those of the control group.
Conclusion: In conclusion, the results of the present study demonstrated that moxidectin and ivermectin administered per os according to the manufacturer's instructions were both effective and safe anthelmintics in sheep. The total milk production was higher in the treated groups than the control group. Overall, animals treated with moxidectin had a milk production 40.8% higher than control group; whereas animals treated with ivermectin had a milk production 32.2% higher than control group.
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
怎么做细胞爬片免疫组化染色实验
细胞爬片免疫组化染色,是通过细胞爬片是让玻片浸在细胞培养基内,细胞在玻片上生长,主要用于组织学,免疫组织化学...
2020/7/20 22:04:33
提取病毒RNA的实验方法
提取病毒RNA方法分别有:异硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26
各种微流控芯片键合方法的优缺点
微流控芯片键合:目前主要有激光焊接、热压键合、胶键合、超音波焊接,每种方法都有各自的优缺点。本文主要介绍聚酯...
2023/7/28 10:43:09
新一代微流控键合解决方案
微流控键合解决方案:微流控芯片制造的一个重要环节,也是最容易被忽视的--芯片键合。其中一个重要因素是:微流控...
2023/7/27 12:44:28
荧光素钾盐使用说明
D-荧光素钾盐(K+)设计用于体外和体内生物发光测定。D-荧光素的质量和纯度对于获得良好和可重复的结果至关重...
2023/7/20 11:05:11
如何选BSA(牛血清白蛋白)
如何选BSA(牛血清白蛋白):牛血清白蛋白(BSA)有多种形式,如何选择适合自己的牛血清白蛋白(BSA)是一...
2023/2/14 13:09:18
牛血清白蛋白(BSA)常见问题
牛血清白蛋白(BSA)常见问题:牛血清白蛋白(BSA)在实验室中是通用的,可用于蛋白质印迹、细胞组织培养、P...
2022/10/19 9:39:51
pubmed使用方法(技巧)
pubmed使用方法(技巧):PubMed是一个关于医学问题的学术文章和书籍的数据库。因为它是一份学术期刊,...
2022/10/18 18:06:07
BSA(牛血清白蛋白)
BSA(牛血清白蛋白):牛血清白蛋白(BSA)是一种球状蛋白质,牛血清白蛋白(BSA)是发现于牛血浆中的主要...
2022/10/18 16:48:12
冻干培养细菌的方法
冻干培养细菌的方法:冷冻干燥,也称为冻干或冷冻干燥,是在产品冷冻后除去水分并将其置于真空中的过程。这使得冰可...
2022/10/16 8:27:31